1301 - 1325 of 6082 Results
Title
Year
- Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes2022OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain ChangesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 1Start Page: 93End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223527Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223527?id=journal-of-parkinsons-disease%2Fjpd223527Citation Count: 14
- Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke2022OPENTitle: Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.122.026901Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.122.026901Citation Count: 12
- Transcriptome Analysis Reveals a Two-Gene Signature Links to Motor Progression and Alterations of Immune Cells in Parkinson’s Disease2022OPENTitle: Transcriptome Analysis Reveals a Two-Gene Signature Links to Motor Progression and Alterations of Immune Cells in Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 1Start Page: 25End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223454Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223454?id=journal-of-parkinsons-disease%2Fjpd223454Citation Count: 3
-
OPENTitle: Genome-wide evaluation of the effect of short tandem repeat variation on local DNA methylationJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 33Issue #: 2Start Page: 184End Page: 196Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1101/gr.277057.122Best OA location URL: https://doi.org/10.1101/gr.277057.122Citation Count: 16
- Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing2022OPENTitle: Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencingJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 28Issue #: 3Start Page: 1327End Page: 1336Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-022-01926-8Best OA location URL: https://www.nature.com/articles/s41380-022-01926-8.pdfCitation Count: 16
-
OPENTitle: High-speed imaging reveals the bimodal nature of dense core vesicle exocytosisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2214897120Best OA location URL: https://doi.org/10.1073/pnas.2214897120Citation Count: 5
- Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy–Richardson Syndrome2022OPENTitle: Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy–Richardson SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 304End Page: 312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29299Best OA location URL: https://doi.org/10.1002/mds.29299Citation Count: 3
- ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease2022OPENTitle: ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01119-zBest OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01119-zCitation Count: 14
- Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach2022OPENTitle: Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class ApproachJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.122.025724Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.122.025724Citation Count: 9
-
OPENTitle: Motor Response With Apomorphine Sublingual Film and Levodopa in Patients With OFF EpisodesJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 13Issue #: 2Start Page: 75End Page: 84Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2022-0038Best OA location URL: https://doi.org/10.2217/nmt-2022-0038Citation Count: 4
- Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording Applications2022OPENTitle: Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording ApplicationsJournal Name: Advanced Electronic MaterialsPublisher: WileyVol: 9Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/aelm.202200883Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/aelm.202200883Citation Count: 11
- Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's disease2022OPENTitle: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 107Issue #:Start Page: 105251End Page: 105251Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251Citation Count: 4
- Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system2022OPENTitle: Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune systemJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2022.1056417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1056417/pdfCitation Count: 21
- Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thickness2022OPENTitle: Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thicknessJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 37Issue #:Start Page: 103300End Page: 103300Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103300Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103300Citation Count: 3
- Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease2022OPENTitle: Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01494-6Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01494-6Citation Count: 71
- Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells2022OPENTitle: Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1114775Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1114775/pdfCitation Count: 1
-
OPENTitle: How to unblur the vasovagal evidence?Journal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 1Start Page: 5End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00915-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00915-9.pdfCitation Count: 1
-
OPENTitle: Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 1Start Page: 12End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01221-3Best OA location URL: https://www.nature.com/articles/s41593-022-01221-3.pdfCitation Count: 195
- The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”2022OPENTitle: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100177End Page: 100177Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100177Citation Count: 1
- Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease2022OPENTitle: Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1061096Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1061096/pdfCitation Count: 7
- Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats2022OPENTitle: Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in ratsJournal Name: Current Research in NeurobiologyPublisher: Elsevier BVVol: 4Issue #:Start Page: 100065End Page: 100065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.crneur.2022.100065Best OA location URL: https://doi.org/10.1016/j.crneur.2022.100065Citation Count: 10
- Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts2022OPENTitle: Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00439-zBest OA location URL: https://www.nature.com/articles/s41531-022-00439-z.pdfCitation Count: 48
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://www.nature.com/articles/s41531-022-00410-y.pdfCitation Count: 181
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147382Citation Count: 37
- Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson's disease2022OPENTitle: Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 57Issue #: 3Start Page: 511End Page: 526Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.15899Citation Count: 13